A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Intravenously Administered MEDI-563, A Humanized Anti-interleukin-5 Receptor Alpha Monoclonal Antibody, on Asthma Control Following Acute Exacerbations in Adults
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008139/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The study will evaluate the effect of two intravenous dose regimens of benralizumab
(MEDI-563) on the proportion of adult subjects with asthma exacerbations who required an
urgent healthcare visit for treatment of an acute asthma exacerbation.
提供机构：
Vivli
创建时间：
2022-06-29
